February 13, 2019
JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange Commission (the "SEC") has declared the Company's Registration Statement on Form 10-12G (the "Form 10") effective as of February 12, 2019. As a res...
February 1, 2019
LOS ANGELES, CA / ACCESSWIRE / February 1, 2019 / LD Micro is pleased to announce that the LD Micro Index is being reconstituted as of February 1, 2019. Again.
January 24, 2019
JUPITER, FL / ACCESSWIRE / January 24, 2019 / Dyadic International, Inc. ("Dyadic" or "the Company") (OTCQX: DYAI) is pleased to announce it has been named to the 2019 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.
January 22, 2019
JUPITER, FL / ACCESSWIRE / January 22, 2019 / Dyadic International, Inc. (the ''Company'') (OTCQX: DYAI) today announced that its CEO, Mark Emalfarb will present at NobleConXV - Noble Capital Markets' Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida - on Monday, January ...
January 15, 2019
JUPITER, FL / ACCESSWIRE / January 15, 2019 / Dyadic International, Inc. (the "Company") ("OTCQX: DYAI) today announced that the Company has filed a replacement Registration Statement on Form 10-12G (the "Replacement Form 10") with the Securities and Exchange Commission (the "Commission").
January 2, 2019
JUPITER, FL / ACCESSWIRE / January 2, 2019 / Due to the federal government shutdown, the Securities and Exchange Commission (the "Commission") has not completed its review of Dyadic International, Inc's. (OTCQX: DYAI) (the "Company") Registration Statement on Form 10-12G (File No. 000-55264), filed ...
November 7, 2018
JUPITER, FL / ACCESSWIRE / November 7, 2018 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development and lower the cost of biologic vaccines and drugs at fl...
November 5, 2018
Data Demonstrate C1 Can Be Developed Into a New-Generation Therapeutic Protein Production System
November 5, 2018
JUPITER, FL / ACCESSWIRE / November 5, 2018 / Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexible ...
October 24, 2018
JUPITER, FL / ACCESSWIRE / October 24, 2018 / Dyadic International, Inc. (''Dyadic'') (OTCQX: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to help speed up the development and production of biologic vaccines and drugs at flexibl...